U-M Medical School sees significant growth in NIH research awards and ranking

4:30 PM

Author | Kelly Malcom

NIH rankings FFY23

In a highly competitive field, Michigan Medicine once again rises to the top. Based on recent federal fiscal year data released by the National Institutes of Health (NIH), the largest single funder of biomedical research in the world, the U-M Medical School is ranked number 11 in the country, up from 13 in federal fiscal year 2022. 

The Medical School’s total market share increased to 2.68% (up from 2.47%) and current NIH funding amounts to $482.8 million, an almost 11% increase over the previous fiscal year. 

Overall, the Medical School received $777.3M in total awards from all sources in FY23.

“Michigan Medicine remains totally committed to advancing our basic science and clinical research. With the support of the NIH and other funding sources, our incredible faculty and teams will lead the future of health care and biomedical research,” said Marschall S. Runge, CEO, Michigan Medicine and Dean, U-M Medical School. 

At the unit level, 70% of departments saw positive growth in funding, and more than half also had a positive change in their NIH ranking.  Two departments, Physiology and Urology, are ranked first in the nation, with four more (Biomedical Engineering, Emergency Medicine, Physical Medicine and Rehabilitation, Surgery) ranked in the top five. Overall, 21 departments are ranked in the top 15 tier, with 17 ranking in the top 10. 

Funding from the NIH makes up the majority of research dollars flowing into academic medical centers in the U.S. Some of the projects reflected in the Medical School’s positive performance include the $71 million Clinical and Translational Science Award supporting the Michigan Institute for Clinical & Health Research (MICHR); a collaborative effort to understand the mechanisms behind kidney disease; funding to support diabetes research, depression treatment and more. Overall, the NIH awarded 933 grants to faculty within the Medical School in federal fiscal year 2023, alone.

In addition to a strong performance in NIH award dollars, the Medical School is continuing to demonstrate consistent expenditure growth across all sponsors as UFY23 had 7.27% increase over UFY22, as researchers put these funds into action. The Medical School accounts for 43% of U-M’s research expenditures.

And while funds from the NIH are a primary source, research at the Medical School is also supported by more than $100 million in awards from non-profits and more than $155 million in industry-sponsored awards. In total, the Medical School received $777.3 million total awards in the university’s fiscal year 2023.

As a result of this investment, many of these projects are leading to potential innovative therapies, moving through the technology transfer process into commercialization. For example, there were 249 invention reports in U-M fiscal year 2023. 

“We owe our ability to attract NIH funding to the dedicated and innovative biomedical research community here at the Medical School. The work of these great minds continues to improve our standing as one of the top research institutions in the nation and allows us to attract the critical collaborations and talent that will lead to great discoveries now and in the future,” said Steven Kunkel, Ph.D., Executive Vice Dean for Research, U-M Medical School and Chief Scientific Officer, Michigan Medicine.

NIH rankings for departments are generated from publicly available data and determined as a percent of the total funding available to medical schools. The full data set published by the NIH is available in the NIH RePORTER:  https://reporter.nih.gov/

Medical school rankings for NIH fiscal year 2023 were also recently compiled by the independent Blue Ridge Institute for Medical Research, which uses a different methodology and placed U-M at number 12.

More Articles About: Medical School
Featured News & Stories The Fundamentals Podcast Hero Card Final 1800 x 1350
The Fundamentals
Cannabis and psychedelics: stigmatized substances or powerful therapeutics?
Today on The Fundamentals is Dr. Kevin Boehnke, research assistant professor in the Department of Anesthesiology and the Chronic Pain and Fatigue Research Center. His current research focuses on therapeutic applications of cannabis and psychedelics. His goal is to rigorously assess appropriate use of these substances and to help address the public health harms caused by their criminalization.
Michigan Medicine Presents in spotlights on blue background
Michigan Medicine Presents
Michigan Medicine Presents: How to Get into Medical School
Join Dr. Deb Berman, assistant dean for admissions, and Carol Teener, director of admissions, along with two current medical students from the University of Michigan Medical School for answers to your questions about getting into medical school and more. The conversation ranges from GPAs and personal statements to the culture and experiences that make Michigan unique.
Watercolor illustration of two women in conversation sitting in chairs and facing each other.
Medicine at Michigan
Q&A: Advice for an aspiring physician
A physician-scientist talks with a new medical student about what it takes to achieve career goals — and work-life balance.
headshot of henry bell. he has glasses and is wearing a tuxedo with a gold and blue bowtie.
Medicine at Michigan
An early injury inspired a career in medicine
When Henry Bell Jr. was a young boy, his sister was mowing the lawn and ran over the rock, which hit him in the eye. He spent two weeks in the hospital and discovered his dream: to become an ophthalmologist.
black and white photo of mustafa saadi standing in front of a building
Medicine at Michigan
From investment banker to future doctor
Mustafa Saadi, M4, started in the finance world and is finding a second career in medicine.
headshot of alice zheng wearing a black blazer and purple blouse
Medicine at Michigan
Alice Zheng was once skeptical of business
The course of Alice Zheng’s life changed when she audited a class at the U-M Ross School of Business during her first year of medical school. Before taking the class, Zheng was skeptical of business. Now she’s a venture capitalist supporting women’s health.